135 related articles for article (PubMed ID: 10085082)
1. Plasmin converts factor X from coagulation zymogen to fibrinolysis cofactor.
Pryzdial EL; Lavigne N; Dupuis N; Kessler GE
J Biol Chem; 1999 Mar; 274(13):8500-5. PubMed ID: 10085082
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity.
Carter RLR; Talbot K; Hur WS; Meixner SC; Van Der Gugten JG; Holmes DT; Côté HCF; Kastrup CJ; Smith TW; Lee AYY; Pryzdial ELG
J Thromb Haemost; 2018 Nov; 16(11):2276-2288. PubMed ID: 30176116
[TBL] [Abstract][Full Text] [Related]
3. Binding of plasminogen and tissue plasminogen activator to plasmin-modulated factor X and factor Xa.
Grundy JE; Lavigne N; Hirama T; MacKenzie CR; Pryzdial EL
Biochemistry; 2001 May; 40(21):6293-302. PubMed ID: 11371191
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic modulation of factor Xa-antithrombin complex enhances fibrinolysis in plasma.
Talbot K; Meixner SC; Pryzdial EL
Biochim Biophys Acta; 2013 Jun; 1834(6):989-95. PubMed ID: 23416531
[TBL] [Abstract][Full Text] [Related]
5. Enhanced fibrinolysis by proteolysed coagulation factor Xa.
Talbot K; Meixner SC; Pryzdial EL
Biochim Biophys Acta; 2010 Apr; 1804(4):723-30. PubMed ID: 19931652
[TBL] [Abstract][Full Text] [Related]
6. Autoproteolysis or plasmin-mediated cleavage of factor Xaalpha exposes a plasminogen binding site and inhibits coagulation.
Pryzdial EL; Kessler GE
J Biol Chem; 1996 Jul; 271(28):16614-20. PubMed ID: 8663221
[TBL] [Abstract][Full Text] [Related]
7. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.
Bergum PW; Cruikshank A; Maki SL; Kelly CR; Ruf W; Vlasuk GP
J Biol Chem; 2001 Mar; 276(13):10063-71. PubMed ID: 11139576
[TBL] [Abstract][Full Text] [Related]
8. Does plasmin have anticoagulant activity?
Hoover-Plow J
Vasc Health Risk Manag; 2010 Apr; 6():199-205. PubMed ID: 20407627
[TBL] [Abstract][Full Text] [Related]
9. Intersection of Coagulation and Fibrinolysis by the Glycosylphosphatidylinositol (GPI)-Anchored Serine Protease Testisin.
Buzza MS; Pawar NR; Strong AA; Antalis TM
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298257
[TBL] [Abstract][Full Text] [Related]
10. Thrombolysis by chemically modified coagulation factor Xa.
Pryzdial EL; Meixner SC; Talbot K; Eltringham-Smith LJ; Baylis JR; Lee FM; Kastrup CJ; Sheffield WP
J Thromb Haemost; 2016 Sep; 14(9):1844-54. PubMed ID: 27359348
[TBL] [Abstract][Full Text] [Related]
11. Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite.
Monteiro RQ; Rezaie AR; Bae JS; Calvo E; Andersen JF; Francischetti IM
Protein Sci; 2008 Jan; 17(1):146-53. PubMed ID: 18042685
[TBL] [Abstract][Full Text] [Related]
12. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor.
Wang W; Boffa MB; Bajzar L; Walker JB; Nesheim ME
J Biol Chem; 1998 Oct; 273(42):27176-81. PubMed ID: 9765237
[TBL] [Abstract][Full Text] [Related]
13. Bacillolysin MA, a novel bacterial metalloproteinase that produces angiostatin-like fragments from plasminogen and activates protease zymogens in the coagulation and fibrinolysis systems.
Narasaki R; Kuribayashi H; Shimizu K; Imamura D; Sato T; Hasumi K
J Biol Chem; 2005 Apr; 280(14):14278-87. PubMed ID: 15677446
[TBL] [Abstract][Full Text] [Related]
14. Hysteresis-like binding of coagulation factors X/Xa to procoagulant activated platelets and phospholipids results from multistep association and membrane-dependent multimerization.
Podoplelova NA; Sveshnikova AN; Kurasawa JH; Sarafanov AG; Chambost H; Vasil'ev SA; Demina IA; Ataullakhanov FI; Alessi MC; Panteleev MA
Biochim Biophys Acta; 2016 Jun; 1858(6):1216-27. PubMed ID: 26874201
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis.
Matsumoto T; Nogami K; Shima M
Thromb Haemost; 2013 Oct; 110(4):761-8. PubMed ID: 24072166
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of plasmin-catalyzed inactivation of factor VIII: a crucial role for proteolytic cleavage at Arg336 responsible for plasmin-catalyzed factor VIII inactivation.
Nogami K; Shima M; Matsumoto T; Nishiya K; Tanaka I; Yoshioka A
J Biol Chem; 2007 Feb; 282(8):5287-95. PubMed ID: 17189254
[TBL] [Abstract][Full Text] [Related]
17. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
[TBL] [Abstract][Full Text] [Related]
18. Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity.
Ajjan RA; Gamlen T; Standeven KF; Mughal S; Hess K; Smith KA; Dunn EJ; Anwar MM; Rabbani N; Thornalley PJ; Philippou H; Grant PJ
Blood; 2013 Jul; 122(1):134-42. PubMed ID: 23699598
[TBL] [Abstract][Full Text] [Related]
19. Substrate delivery mechanism and the role of membrane curvature in factor X activation by extrinsic tenase.
Kovalenko TA; Panteleev MA; Sveshnikova AN
J Theor Biol; 2017 Dec; 435():125-133. PubMed ID: 28935233
[TBL] [Abstract][Full Text] [Related]
20. Active site-specific immunoassays.
Mann KG; Williams EB; Krishnaswamy S; Church W; Giles A; Tracy RP
Blood; 1990 Aug; 76(4):755-66. PubMed ID: 2116928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
